Laser Treatment of Erythema and Telangiectasia Associated with Rosacea (original) (raw)

Abstract

The response of rosacea-associated erythema and telangiectasia to treatment with the pulsed tunable dye laser (PDL) was evaluated in 12 patients. Improvements in erythema, telangiectasia, flushing, the physician's and the patient's perception of overall severity, treatment tolerability, and the adverse side effects were examined. With the sole exception of the patient's assessment of overall severity we have found highly significant improvements in all other parameters evaluated, with excellent tolerance of treatment. We therefore conclude that the PDL is a safe and effective treatment for the erythemato-telangiectatic component of rosacea.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Departments of Dermatology, The University Hospital of Wales, Heath Park, Cardiff, UK, GB
    S.M. Clark & R. Marks
  2. The Princess of Wales Hospital, Bridgend, UK, GB
    S.W. Lanigan

Authors

  1. S.M. Clark
  2. S.W. Lanigan
  3. R. Marks

Additional information

Paper received 13 March 2001; accepted after revision 26 June 2001.

Rights and permissions

About this article

Cite this article

Clark, S., Lanigan, S. & Marks, R. Laser Treatment of Erythema and Telangiectasia Associated with Rosacea.Lasers Med Sci 17, 26–33 (2002). https://doi.org/10.1007/s10103-002-8263-8

Download citation